Koesten Hirschmann & Crabtree’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.2M Buy
55,307
+8,051
+17% +$749K 2.17% 7
2026
Q2
$4.56M Buy
47,256
+11,527
+32% +$1.06M 1.9% 9
2026
Q1
$2.88M Buy
35,729
+8,359
+31% +$694K 1.4% 12
2025
Q4
$2.11M Buy
27,370
+27,231
+19,591% +$2.08M 1.04% 13
2025
Q3
$10.4K Buy
+139
New +$9.9K 0.01% 139

Other funds holding AVEM

Koesten Hirschmann & Crabtree's AVEM Position: Q3 2026 in Review

Koesten Hirschmann & Crabtree increased its Avantis Emerging Markets Equity ETF (AVEM) stake by 17% in Q3 2026, buying an estimated $749K and bringing the position to 55,307 shares worth $5.2M. The position accounts for 2.17% of the portfolio, ranked #7.

Koesten Hirschmann & Crabtree first reported a position in AVEM in Q3 2025 and has held it in 5 quarters since. 720 funds tracked by Wall St. Rank hold AVEM as of Q3 2026.

  • Koesten Hirschmann & Crabtree held 55,307 shares of Avantis Emerging Markets Equity ETF worth $5.2M as of Q3 2026.
  • Koesten Hirschmann & Crabtree bought 8,051 Avantis Emerging Markets Equity ETF shares in Q3 2026, an estimated $749K.
  • Avantis Emerging Markets Equity ETF made up 2.17% of Koesten Hirschmann & Crabtree's portfolio in Q3 2026, its #7 holding.
  • Koesten Hirschmann & Crabtree first reported a position in Avantis Emerging Markets Equity ETF in Q3 2025 and has held it in 5 quarters since.
  • 720 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q3 2026.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q3 2026, filed 13 Oct 2026.